Previous close | 1.7700 |
Open | 1.7400 |
Bid | 1.7400 x 200 |
Ask | 1.7700 x 300 |
Day's range | 1.7050 - 1.7700 |
52-week range | 1.4550 - 5.6500 |
Volume | |
Avg. volume | 495,712 |
Market cap | 113.353M |
Beta (5Y monthly) | 1.65 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
REDWOOD CITY, Calif., April 23, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced that it will report financial results for the first quarter 2024 on Wednesday, May 8, 2024. Company management will be webcasting a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Live audio of the webcast will be available on the Investor section of Seer’s website at investor.se
Enhanced access to the Proteograph Product Suite and demonstrated its power with new customer dataREDWOOD CITY, Calif., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today reported financial results for the fourth quarter and full year ended December 31, 2023. Recent Highlights Achieved revenue of $4.4 million for the fourth quarter of 2023, a decrease of 4% over the fourth quarter of 2022, a
REDWOOD CITY, Calif., Feb. 21, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced that the company will be participating in the upcoming TD Cowen 44th Annual Health Care Conference in Boston, MA. Seer’s management is scheduled to participate in a fireside chat and Q&A session on Monday, March 4th at 1:30 p.m. Eastern Time / 10:30 a.m. Pacific Time. A live webcast of the session will be avai